Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

ADC Therapeutics SA (ADCT)

NYSE

$1.10

$+0.03

(+2.70%)

Pre-Market

ADC Therapeutics SA (ADCT) Live Price Chart

Last updated: ⁦2026-09-15 09:16:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

ADC Therapeutics SA (ADCT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1.10, with a market capitalisation of $136.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.78 to $4.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$136.60M
Open	$1.10
Day's High	$56.59
Day's Low	$0.36
Previous Close	$1.11
Volume	1.00K
Average Volume	1.43M
P/E Ratio	--
52-Week High	$4.98
52-Week Low	$0.78
Dividend Yield	--
Earnings Date	--

ADC Therapeutics SA (ADCT) Pre-Market Stock Price

ADC Therapeutics SA (ADCT) is trading at $1.10 in pre-market trading as of 2026-09-15 08:23:00, down 0.90% ($0.01) from the previous close of $1.11

Pre-market trading shows how investors are pricing ADCT before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

ADC Therapeutics SA (ADCT) 7-Day Stock Price Change

Over the past seven days, ADC Therapeutics SA (ADCT) moved from $1.32 to $1.10, representing a decline of 16.67% ($0.22).

The stock traded between $1.04 and $1.37 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.38 million shares, down versus the previous seven-day period, indicating lower trading activity.

ADCT 52-Week Price Position

Position in Range: 7.6%

52W Low$0.78

52W High$4.98

ADCT is currently trading at $1.10, placing it 7.6% of the way from its 52-week low of $0.78 to its 52-week high of $4.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ADC Therapeutics SA (ADCT)?

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

ADC Therapeutics SA Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	193
Exchange	NYSE
Company Website	https://www.adctherapeutics.com

How to Buy ADC Therapeutics SA (ADCT) Stock on MEXC

Eligible investors can buy real shares of ADC Therapeutics SA (ADCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ADCT and Place Your Order

Open the RealStocks trading page and search for ADCT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ADC Therapeutics SA (ADCT) stock price today?

ADC Therapeutics SA (ADCT) is currently trading at $ 1.10, down 0.90% ($0.01) from the previous close of $ 1.11. Intraday prices update in real time during regular trading hours.

2.Is ADCT stock going up or down today?

As of 2026-09-15 08:23:00, ADCT is trading at $ 1.10, down 0.90% ($0.01) from its previous close of $ 1.11. The stock has traded between $ 0.36 and $ 56.59 during today’s regular session. Past price movements do not guarantee future results.

3.What is ADCT pre-market price?

As of 2026-09-15 08:23:00, ADCT is trading at $ 1.10 in pre-market trading, down 0.90% ($0.01) from the previous close of $ 1.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ADCT after-hours price?

As of 2026-09-15 08:23:00, ADCT is trading at $ 1.10 in after-hours trading, down 0.90% ($0.01) from the regular-session close of $ 1.11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ADCT stock trading now?

ADCT trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ADCT sit relative to its 52-week high and low?

Over the past 52 weeks, ADCT has traded between a low of $ 0.78 and a high of $ 4.98. At $ 1.10, the stock is positioned 7.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ADC Therapeutics SA in?

ADC Therapeutics SA (ADCT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ADC Therapeutics SA's market capitalisation and where is it listed?

ADC Therapeutics SA is listed on the NYSE exchange with a market capitalisation of $ 136.60M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ADCT valued in terms of P/E ratio and EPS?

ADCT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.76. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ADC Therapeutics SA pay a dividend?

ADC Therapeutics SA pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.